Many people in Britain are experiencing a enigmatic and incapacitating skin disorder that has stumped doctors. Sufferers describe their skin as becoming severely inflamed, cracked and peeling, commonly affecting large areas of their body, yet many doctors struggle to diagnose or treat the condition. The phenomenon, called topical steroid withdrawal (TSW) or red skin syndrome, has generated significant attention on social media, with footage showing patients’ experiences accumulating over one billion views on TikTok alone. Even though it impacts a increasing number of people, TSW remains so inadequately understood that some doctors and dermatologists query whether it actually exists at all. Now, for the first time, researchers in the UK are commencing a significant research project to investigate what is behind these mysterious symptoms and reasons why some people develop the condition whilst others do not.
The Puzzling Ailment Sweeping Across the UK
Bethany Gamble’s case exemplifies the devastating impact of topical steroid withdrawal on patients’ wellbeing. The 21-year-old from Birmingham had controlled her eczema well with steroid creams since childhood, but at eighteen, her condition took a dramatic turn for the worse. Her skin became acutely inflamed with redness, splitting and weeping whilst the itching became what she describes as “bone deep”. Within two years, the pain had become so intense that she was confined to her bed, requiring round-the-clock care from her mother. Most distressing of all, Bethany experienced repeated dismissal by medical professionals who blamed her symptoms on standard eczema and continued prescribing the very treatments she believed were causing her suffering.
The healthcare sector continues to disagree on how to manage TSW, with deep divisions about its very nature. Some experts regard it as a severe allergic response to the steroid-based creams that form the first-line treatment for eczema across the NHS. Others contend it constitutes a acute flare-up of pre-existing skin conditions rather than a separate syndrome, whilst a handful are sceptical of its existence altogether. This professional uncertainty has left patients like Bethany stuck in a diagnostic uncertainty, finding it hard to obtain proper treatment. The failure to reach consensus has led Professor Sara Brown at the University of Edinburgh to set up the inaugural major UK research project examining TSW, supported by the National Eczema Society.
- Symptoms involve severe inflammation, skin fissuring and intense itching across the body
- Patients report “elephant skin” thickening and excessive flaking of keratinised cells
- Healthcare practitioners commonly disregard TSW as standard eczema or refuse to acknowledge it
- The condition may prove so incapacitating that sufferers become unable to carry out everyday tasks
Living with Topical Steroid Withdrawal
From Controllable Eczema to Debilitating Symptoms
For numerous sufferers, withdrawal from topical steroids represents a severe decline from a formerly stable dermatological condition. What starts with intermittent itching in skin creases can rapidly escalate into a full-body inflammatory response that leaves patients unable to function. The transition often occurs abruptly, unexpectedly, transforming a manageable chronic condition into an severe medical emergency. Patients report their skin becoming intensely hot, red and inflamed, with severe cracking and oozing that demands ongoing care. The bodily burden is compounded by exhaustion, as the relentless itching disrupts sleep and healing, creating a destructive cycle of deterioration.
The speed at which TSW develops takes many sufferers off guard. Those who have lived with eczema for years, sometimes decades, are unprepared for the severity of symptoms that appear when their condition suddenly worsens. Simple daily activities become monumental challenges: showering becomes excruciating, dressing requires assistance, and keeping clean demands enormous effort. Some patients describe feeling as though their skin is being ravaged from within, with inflammation moving through their body in patterns that bear little resemblance to their earlier flare-ups. This striking change often leads sufferers to pursue immediate medical attention, only to encounter scepticism from healthcare professionals.
The Push for Recognition
Perhaps the cruelest aspect of topical steroid withdrawal is the dismissive medical responses that frequently accompanies it. Patients experiencing serious, unexplained health issues are routinely told they merely suffer from eczema worsening, despite their assertion that this is fundamentally different from anything they’ve encountered previously. Doctors frequently react by prescribing stronger steroids or increased doses, potentially worsening the very condition patients believe the creams caused. This cycle of dismissal leaves sufferers feeling abandoned by the medical establishment, forced to navigate their illness alone whilst being told their lived experience is invalid. Many patients report feeling gaslit repeatedly, their concerns dismissed as emotional or psychological in nature rather than genuine physiological symptoms.
The absence of professional agreement has established a dangerous gap between patient experience and clinical acknowledgement. Without clear diagnostic criteria or defined treatment approaches, general practitioners and skin specialists find it difficult to diagnose TSW or provide suitable care. Some clinicians remain entirely unconvinced the condition exists, viewing all acute cases as standard eczema or other known dermatological conditions. This professional uncertainty translates into delayed diagnosis, inappropriate treatment and significant emotional suffering for people experiencing physical symptoms. The growing visibility of TSW on social media has drawn attention to this diagnostic void, encouraging investigation to investigate what thousands of people claim to be experiencing, even as the medical establishment continues to disagree on the appropriate response.
- Signs may develop abruptly in individuals with previously stable eczema treated by steroid creams
- Patients often face scepticism from medical practitioners who attribute worsening to typical eczema exacerbations
- Medical professionals remain divided on whether TSW is a genuine condition or acute eczema flare-up
- Absence of established diagnostic standards means numerous patients struggle to access suitable care and support
- Online platforms has amplified patient voices, with TSW hashtags reaching more than one billion views globally
Racial Inequities in Diagnosis and Care
The diagnostic difficulties surrounding TSW become increasingly evident amongst people with darker skin tones, where symptoms can be substantially more challenging to detect visually. Redness and inflammation, the characteristic indicators of TSW in those with lighter complexions, manifest differently across different ethnic groups, yet many assessment protocols remain focused on how the condition appears in white patients. This gap means that individuals from Black, Asian and minority ethnic backgrounds experiencing TSW frequently encounter substantially longer periods in recognition and validation. Healthcare professionals trained chiefly via presentations in lighter skin may miss or misread the characteristic signs, causing additional diagnostic errors and unsuitable therapeutic suggestions that can worsen symptoms.
Research into TSW has historically overlooked the experiences of people with darker complexions, perpetuating a cycle where their symptoms remain under-documented and under-studied. The online discussions shaping TSW discourse have been largely shaped by voices with lighter skin, risking distortion of clinical knowledge and public awareness. As Professor Sara Brown’s groundbreaking UK study progresses, guaranteeing inclusive participation amongst research participants will be essential to creating genuinely comprehensive diagnostic criteria and treatment approaches. Without intentional action to centre the experiences of diverse populations, treatment inequalities in TSW recognition and management risk widening further, abandoning at-risk communities without sufficient assistance or solutions.
| Skin Tone | TSW Appearance |
|---|---|
| Light/Fair | Bright red inflammation, visible flushing and erythema across affected areas |
| Medium/Olive | Darker red or brownish discolouration with less pronounced visible redness |
| Dark/Deep | Purple-toned or ashen discolouration, with inflammation appearing as hyperpigmentation or hypopigmentation |
| Very Dark | Subtle changes in skin texture and tone, with inflammation manifesting as dark patches or loss of pigmentation |
Research and Treatment Approaches Coming to Light
Leading UK Study Underway
Professor Sara Brown’s groundbreaking research at the Edinburgh University marks a watershed moment for TSW sufferers pursuing validation and understanding. Funded by the National Eczema Society, the study has enrolled hundreds of participants in the UK to investigate the physiological processes driving topical steroid withdrawal. By analysing symptoms, saliva samples and skin biopsies, researchers aim to identify why some people experience TSW whilst others on identical steroid regimens do not. This scientific scrutiny marks a important transition from dismissal to rigorous examination.
The research team partnering with Dr Alice Burleigh from patient advocacy group Scratch That, brings both clinical expertise and firsthand experience to the study. Their collaborative approach recognises that patients hold vital knowledge into their conditions. Professor Brown has noted patterns in TSW that cannot be accounted for by conventional eczema understanding, including marked “elephant skin” thickening, pronounced shedding and sharply demarcated zones of inflammation. The study results could significantly transform how healthcare practitioners manage diagnosis and treatment of this debilitating condition.
Treatment Options and Their Limitations
At present, therapeutic approaches to TSW continue to be limited and often unsatisfactory. Many clinicians keep prescribing topical steroids notwithstanding evidence indicating they could worsen symptoms in vulnerable patients. Some patients report temporary relief from moisturisers, antihistamines and systemic drugs, though responses vary considerably. Dermatologists remain divided on best treatment approaches, with some recommending full steroid withdrawal whilst others advocate phased withdrawal. This absence of agreement leaves patients navigating their therapeutic pathways predominantly by themselves, drawing substantially on peer support networks and digital communities for advice.
Psychological assistance with specialist dermatological care offer potential benefits, yet access is inconsistent across the NHS. Some patients have investigated complementary methods including dietary modifications, environmental controls and whole-person treatment approaches, though scientific evidence validating such approaches is limited. The absence of established clinical protocols means treatment decisions frequently rely upon individual dermatologist experience and patient preference rather than evidence-based guidelines. Until robust research produces definitive answers, TSW sufferers frequently describe feeling abandoned by conventional medicine.
- Emollient creams and hydrating products to maintain skin barrier function and minimise water loss
- Antihistamines to control itching and related sleep disruption in flare episodes
- Oral corticosteroids or immune-suppressing agents for serious presentations under specialist supervision
- Therapeutic counselling to manage emotional distress and worry related to chronic skin conditions
Expressions of Hope and Commitment
Despite the lack of clarity regarding TSW and the often dismissive perspectives from medical practitioners, patients are drawing strength in community and shared experience. Digital support communities have emerged as lifelines for those contending with the condition, providing practical guidance and validation when traditional medicine has let them down. Many sufferers describe the point at which they found the TSW hashtag as transformative—finally finding others with the same symptoms and recognising they were not isolated in their suffering. This collective voice has proven powerful enough to spark the first serious research efforts, demonstrating that patient-led campaigns can advance medical understanding even when established institutions stay unconvinced.
Bethany Gamble and people in similar situations are committed to raise awareness and advocate for appropriate acknowledgement of TSW within the medical community. Their openness in recount personal stories of their challenges on social media has normalised conversations around a disorder that many doctors still refuse to acknowledge. These patients are not waiting passively for answers; they are taking part in scientific investigations, tracking their signs thoroughly, and insisting that their accounts be taken seriously. Their determination in the midst of ongoing pain and medical gaslighting suggests possibility that answers may finally be within reach, and that upcoming sufferers will receive the recognition and support they so desperately need.
- Patient-led research initiatives are addressing shortcomings left by traditional medical institutions and accelerating understanding of TSW
- Digital support networks offer psychological assistance, actionable management techniques, and mutual recognition for isolated sufferers globally
- Campaign work are incrementally changing clinical attitudes, encouraging dermatologists to investigate rather than overlook individual accounts
